Last week, the trial of Theranos Founder Elizabeth Holmes kicked off, a 13-week long journey to test her innocence against 10 counts of wire fraud and two counts of conspiracy to commit wire fraud. Locally Scangroup is soaring, despite a 22% dip in revenue and a Ksh 1.732 Billion loss in 2020. US stock indices were bloody red. Listen to this episode to find out why investors are buying ScanGroup, lessons to learn from investors who bled after Theranos’ failed tests, and why Global indices fell last week.
Binge on all our podcasts on markets, tech, and policy on the Hisa App available on the Google Playstore and the Apple Apple Appstore.
This episode features:
Felix Ochieng – Chief Financial Analyst, Hisa
Mwakaneno Gakweli – Podcast Producer and Host, Hisa.